Search research articles
Contact Us
Filters
Showing results (121-130 of 378) with videos related to
Page
of 38
Sort By:
Journal of the American College of Surgeons
|
February 28, 2006
Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Cord Sturgeon, Wen T Shen, Orlo H Clark, et al.
Head & Neck
|
March 19, 2015
Quantitative reverse transcription polymerase chain reaction-based detection of thyroid-specific gene expression in fine-needle aspirate for thyroid cancer recurrence evaluation: a case report and review of the literature
Saïd C Azoury, Rachel Aufforth, Mei He, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2024
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Jiangnan Hu, Kaili Liu, Chandrayee Ghosh, et al.
Surgery
|
January 20, 2005
Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas
Wen T Shen, Cord Sturgeon, Orlo H Clark, et al.
Nature Communications
|
October 11, 2018
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Sudheer Kumar Gara, Justin Lack, Lisa Zhang, et al.
Journal of Clinical Medicine
|
May 17, 2020
Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not?
Tae-Yon Sung, Wilson Mawutor Alobuia, Monica Varun Tyagi, et al.
Journal of the American College of Surgeons
|
June 1, 2005
Extent of disease and practice patterns for medullary thyroid cancer
Electron Kebebew, Francis S Greenspan, Orlo H Clark, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2013
An in vivo mouse model of metastatic human thyroid cancer
Lisa Zhang, Kelli Gaskins, Zhiya Yu, et al.
Endocrine-Related Cancer
|
March 28, 2013
TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma
Meenu Jain, Lisa Zhang, Mei He, et al.
Surgery
|
July 25, 2009
Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy?
Wen T Shen, Electron Kebebew, Insoo Suh, et al.
Page
of 38
Search research articles
Search
Showing results (121-130 of 378) with videos related to
Sort By:
Page
of 38
Journal of the American College of Surgeons
|
February 28, 2006
Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Cord Sturgeon, Wen T Shen, Orlo H Clark, et al.
Head & Neck
|
March 19, 2015
Quantitative reverse transcription polymerase chain reaction-based detection of thyroid-specific gene expression in fine-needle aspirate for thyroid cancer recurrence evaluation: a case report and review of the literature
Saïd C Azoury, Rachel Aufforth, Mei He, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 19, 2024
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Jiangnan Hu, Kaili Liu, Chandrayee Ghosh, et al.
Surgery
|
January 20, 2005
Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas
Wen T Shen, Cord Sturgeon, Orlo H Clark, et al.
Nature Communications
|
October 11, 2018
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Sudheer Kumar Gara, Justin Lack, Lisa Zhang, et al.
Journal of Clinical Medicine
|
May 17, 2020
Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not?
Tae-Yon Sung, Wilson Mawutor Alobuia, Monica Varun Tyagi, et al.
Journal of the American College of Surgeons
|
June 1, 2005
Extent of disease and practice patterns for medullary thyroid cancer
Electron Kebebew, Francis S Greenspan, Orlo H Clark, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2013
An in vivo mouse model of metastatic human thyroid cancer
Lisa Zhang, Kelli Gaskins, Zhiya Yu, et al.
Endocrine-Related Cancer
|
March 28, 2013
TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma
Meenu Jain, Lisa Zhang, Mei He, et al.
Surgery
|
July 25, 2009
Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy?
Wen T Shen, Electron Kebebew, Insoo Suh, et al.
Page
of 38